FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794162729> ?p ?o ?g. }

• W2794162729 endingPage "690" @default.
• W2794162729 startingPage "683" @default.
• W2794162729 abstract "Few trials have examined rates of hypersensitivity reactions (HSRs) with intravenous iron formulations used to treat iron deficiency anemia (IDA). This randomized, multicenter, double-blind clinical trial compared the safety, and efficacy of ferumoxytol versus ferric carboxymaltose (FCM), focusing on rates of HSRs and hypotension as the primary end point. Patients with IDA of any etiology in whom oral iron was unsatisfactory or intolerable received ferumoxytol (n = 997) or FCM (n = 1000) intravenously over ≥15 minutes on days 1 and 8 or 9 for total respective doses of 1.02 g and 1.50 g. Composite incidences of moderate-to-severe HSRs, including anaphylaxis, or moderate-to-severe hypotension from baseline to week 5 (primary safety end point) were 0.6% and 0.7% in the ferumoxytol and FCM groups, respectively, with ferumoxytol noninferior to FCM. No anaphylaxis was reported in either group. The secondary safety end point of incidences of moderate-to-severe HSRs, including anaphylaxis, serious cardiovascular events, and death from baseline to week 5 were 1.3% and 2.0% in the ferumoxytol and FCM groups, respectively (noninferiority test P < .0001). Least-squares mean changes in hemoglobin at week 5 were 1.4 g/dL and 1.6 g/dL in the ferumoxytol and FCM groups, respectively (noninferiority test P < .0001). Incidence of hypophosphatemia was 0.4% for ferumoxytol and 38.7% for FCM." @default.
• W2794162729 created "2018-03-29" @default.
• W2794162729 creator A5021273139 @default.
• W2794162729 creator A5027085946 @default.
• W2794162729 creator A5057509756 @default.
• W2794162729 creator A5068978392 @default.
• W2794162729 creator A5071917576 @default.
• W2794162729 creator A5074008977 @default.
• W2794162729 creator A5077715237 @default.
• W2794162729 creator A5086489225 @default.
• W2794162729 date "2018-02-24" @default.
• W2794162729 modified "2023-10-05" @default.
• W2794162729 title "Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial" @default.
• W2794162729 cites W1492831809 @default.
• W2794162729 cites W1498732084 @default.
• W2794162729 cites W1863012309 @default.
• W2794162729 cites W2009298875 @default.
• W2794162729 cites W2020450527 @default.
• W2794162729 cites W2043337324 @default.
• W2794162729 cites W2049123117 @default.
• W2794162729 cites W2052951012 @default.
• W2794162729 cites W2053485995 @default.
• W2794162729 cites W2056969309 @default.
• W2794162729 cites W2061005955 @default.
• W2794162729 cites W2065483932 @default.
• W2794162729 cites W2082400843 @default.
• W2794162729 cites W2124571377 @default.
• W2794162729 cites W2128540381 @default.
• W2794162729 cites W2148904824 @default.
• W2794162729 cites W2152551343 @default.
• W2794162729 cites W2169161951 @default.
• W2794162729 cites W2179358297 @default.
• W2794162729 cites W2222807855 @default.
• W2794162729 cites W2554875069 @default.
• W2794162729 cites W2557622425 @default.
• W2794162729 cites W2559621924 @default.
• W2794162729 cites W2582245763 @default.
• W2794162729 cites W2604745390 @default.
• W2794162729 cites W2759369307 @default.
• W2794162729 doi "https://doi.org/10.1002/ajh.25060" @default.
• W2794162729 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5947731" @default.
• W2794162729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29417614" @default.
• W2794162729 hasPublicationYear "2018" @default.
• W2794162729 type Work @default.
• W2794162729 sameAs 2794162729 @default.
• W2794162729 citedByCount "89" @default.
• W2794162729 countsByYear W27941627292018 @default.
• W2794162729 countsByYear W27941627292019 @default.
• W2794162729 countsByYear W27941627292020 @default.
• W2794162729 countsByYear W27941627292021 @default.
• W2794162729 countsByYear W27941627292022 @default.
• W2794162729 countsByYear W27941627292023 @default.
• W2794162729 crossrefType "journal-article" @default.
• W2794162729 hasAuthorship W2794162729A5021273139 @default.
• W2794162729 hasAuthorship W2794162729A5027085946 @default.
• W2794162729 hasAuthorship W2794162729A5057509756 @default.
• W2794162729 hasAuthorship W2794162729A5068978392 @default.
• W2794162729 hasAuthorship W2794162729A5071917576 @default.
• W2794162729 hasAuthorship W2794162729A5074008977 @default.
• W2794162729 hasAuthorship W2794162729A5077715237 @default.
• W2794162729 hasAuthorship W2794162729A5086489225 @default.
• W2794162729 hasBestOaLocation W27941627291 @default.
• W2794162729 hasConcept C126322002 @default.
• W2794162729 hasConcept C126838900 @default.
• W2794162729 hasConcept C143409427 @default.
• W2794162729 hasConcept C168563851 @default.
• W2794162729 hasConcept C203092338 @default.
• W2794162729 hasConcept C2776732101 @default.
• W2794162729 hasConcept C2777417653 @default.
• W2794162729 hasConcept C2778248108 @default.
• W2794162729 hasConcept C2778917026 @default.
• W2794162729 hasConcept C2909801847 @default.
• W2794162729 hasConcept C71924100 @default.
• W2794162729 hasConcept C90924648 @default.
• W2794162729 hasConceptScore W2794162729C126322002 @default.
• W2794162729 hasConceptScore W2794162729C126838900 @default.
• W2794162729 hasConceptScore W2794162729C143409427 @default.
• W2794162729 hasConceptScore W2794162729C168563851 @default.
• W2794162729 hasConceptScore W2794162729C203092338 @default.
• W2794162729 hasConceptScore W2794162729C2776732101 @default.
• W2794162729 hasConceptScore W2794162729C2777417653 @default.
• W2794162729 hasConceptScore W2794162729C2778248108 @default.
• W2794162729 hasConceptScore W2794162729C2778917026 @default.
• W2794162729 hasConceptScore W2794162729C2909801847 @default.
• W2794162729 hasConceptScore W2794162729C71924100 @default.
• W2794162729 hasConceptScore W2794162729C90924648 @default.
• W2794162729 hasIssue "5" @default.
• W2794162729 hasLocation W27941627291 @default.
• W2794162729 hasLocation W27941627292 @default.
• W2794162729 hasLocation W27941627293 @default.
• W2794162729 hasOpenAccess W2794162729 @default.
• W2794162729 hasPrimaryLocation W27941627291 @default.
• W2794162729 hasRelatedWork W2070305242 @default.
• W2794162729 hasRelatedWork W2074768907 @default.
• W2794162729 hasRelatedWork W2152551343 @default.
• W2794162729 hasRelatedWork W22040025 @default.
• W2794162729 hasRelatedWork W2291075142 @default.
• W2794162729 hasRelatedWork W2908540378 @default.

• next